Here is a little analysis for you. All the stuff CTSO promotes and the propoganda sounds great, however, if you look deaper into the company over the last 5 years you will see what I see.
- $1,000,000 in sales every 90 days
- Each patient amounts to approximately $3,500 in revenue for 1 treatment
- This equals roughly 286 patients treated per every 90 days
- This equals about 3 patients treated PER DAY globally
How many countries are we in? How many territories are we selling in? It has been over 5 years and the company is still STRUGGLING for legitmate clinical data - am I incorrect? Company has no medically acceptable data, it has been 5 years and we are treating 3 patients per day. WOW....
Market cap is $200M when fully diluted and we are producing around $4M in annual revenue. This is a price to sales ratio of 50:1. Still think the stock is cheap? Sales of around $50M would give it a P/S ratio of 4:1. Net profit margin of 25% would yield a EPS of around $0.45 and at a P/E ratio of 20:1 that would give a price of $8.93.
For those of you that think the stock is a baby and the market is not fairly valuing the potential - it looks like they actually are. I do not see 3+ year sales being $50M.
Go ahead and throw some comparables at me for other companies trading at more agressive multiples. Touche for them. They are not CTSO. They do not have botched clinical trials and the OTC feel that this now NASDAQ listed company has.
News 
Market Data 
Discover 
AI
